Miocardiopatía periparto: afección subvalorada

Q4 Medicine Medicina Interna de Mexico Pub Date : 2019-09-25 DOI:10.24245/mim.v35i5.2661
Blanca Estela Herrera-Morales, Juan Lara-Cruz, Alfredo Arellano-Ramírez
{"title":"Miocardiopatía periparto: afección subvalorada","authors":"Blanca Estela Herrera-Morales, Juan Lara-Cruz, Alfredo Arellano-Ramírez","doi":"10.24245/mim.v35i5.2661","DOIUrl":null,"url":null,"abstract":"Pregnancy is a state that imposes a real challenge for the maternal cardiovascular system. There is a cardiac remodeling, which along with an increase in myocardial mass, in left ventricular size and decreased myocardial contractility aggravated by changes in pregnancy, can condition acute heart failure during the peripartum period. Peripartum cardiomyopathy is when the systolic function of the left ventricle and the symptoms of heart failure occur in the last month of pregnancy and in the five months after delivery with an incidence ranging from 1/1300 to 1/15,000 pregnancies. This paper reports the case of a 26-year-old female patient, who had a history of congenital cataract, with normal pregnancy and eutocic delivery; during the puerperium patient showed dyspnea, hypoperfusion data and pulmonary and cardiac ultrasonographic evaluation of peripartum dilated cardiomyopathy, being transferred at a third level, where despite intensive multidisciplinary treatment, the patient died. Peripartum cardiomyopathy is an undervalued disease that has a high maternal and perinatal mortality; however, a timely detection can improve treatment and prognosis. The purpose of this case report is to demonstrate the importance of early detection of a poorly diagnosed entity, such as peripartum cardiomyopathy.","PeriodicalId":35750,"journal":{"name":"Medicina Interna de Mexico","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medicina Interna de Mexico","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.24245/mim.v35i5.2661","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Pregnancy is a state that imposes a real challenge for the maternal cardiovascular system. There is a cardiac remodeling, which along with an increase in myocardial mass, in left ventricular size and decreased myocardial contractility aggravated by changes in pregnancy, can condition acute heart failure during the peripartum period. Peripartum cardiomyopathy is when the systolic function of the left ventricle and the symptoms of heart failure occur in the last month of pregnancy and in the five months after delivery with an incidence ranging from 1/1300 to 1/15,000 pregnancies. This paper reports the case of a 26-year-old female patient, who had a history of congenital cataract, with normal pregnancy and eutocic delivery; during the puerperium patient showed dyspnea, hypoperfusion data and pulmonary and cardiac ultrasonographic evaluation of peripartum dilated cardiomyopathy, being transferred at a third level, where despite intensive multidisciplinary treatment, the patient died. Peripartum cardiomyopathy is an undervalued disease that has a high maternal and perinatal mortality; however, a timely detection can improve treatment and prognosis. The purpose of this case report is to demonstrate the importance of early detection of a poorly diagnosed entity, such as peripartum cardiomyopathy.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
围产期心肌病:低估的情况
怀孕是一种对母亲心血管系统构成真正挑战的状态。心脏重塑,伴随着心肌质量的增加、左心室大小的增加和因妊娠变化而加剧的心肌收缩力的降低,可能会导致围产期急性心力衰竭。围产期心肌病是指左心室收缩功能和心力衰竭症状发生在妊娠的最后一个月和产后五个月,发病率为1/1300至1/15000。本文报告了一例26岁的女性患者,她有先天性白内障病史,正常妊娠并分娩;在产褥期,患者表现出呼吸困难、低灌注数据以及肺和心脏超声评估的围产期扩张型心肌病,被转移到第三级,尽管进行了强化的多学科治疗,患者还是死亡了。围产期心肌病是一种被低估的疾病,具有较高的孕产妇和围产期死亡率;然而,及时发现可以改善治疗和预后。本病例报告的目的是证明早期发现诊断不佳的实体的重要性,如围产期心肌病。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Medicina Interna de Mexico
Medicina Interna de Mexico Medicine-Internal Medicine
CiteScore
0.30
自引率
0.00%
发文量
137
期刊介绍: La revista Medicina Interna de México es el órgano oficial del Colegio de Medicina Interna de México Reserva de Titulo de la Dirección General del Derecho de Autor (SEP) número 04-2001-112110545900.-102 certificado de Licitud de Titulo número 11967 y Certilicado de Licitud de Contenido de la Comisión Catificadora de Publicaciones y Revistas Ilustradas (SeGob) número 8375. AutorIzada por SEPOMEX como Publicación Penódica Registro número PPO9- 0884
期刊最新文献
The evolution of pharmacological treatment of COVID-19 COVID-19, that global parenthesis Cardiovascular, hematological and renal implications of COVID-19 Acute kidney injury as a predictor of hospital discharge in COVID-19 patients Telogen effluvium and alopecia areata: Associated symptoms in patients with long COVID-19
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1